Leeds BRC’s Prof. Del Galdo co-leads new EULAR guidelines for systemic sclerosis treatment
Professor Del Galdo, Workstream 3 lead for Musculoskeletal Disease at Leeds Biomedical Research Centre (BRC), has collaborated with experts across Europe and the Middle East to establish comprehensive, evidence-based guidance for the treatment and management of systemic sclerosis (SSc).